Discover Delcath’s innovative liver-targeted chemotherapy system and latest clinical data driving potential market expansion.

Investing.com -- Genmab A/S (CSE:GMAB) shares fell more than 3% on Monday after new data from Johnson & Johnson ’s amivantamab suggested the drug could rival Genmab and Merus N.V. ’s petosemtamab in ...

AdvaMed wants to work with the Trump administration "to recognize and to reward the unique strength of the U.S. medtech ...

The decision to implement Grap Stage 2 was taken just ahead of Diwali, when the air quality in Delhi-NCR spiked to over 300.

A 31-year-old woman’s mild urinary infection escalated into kidney stones and septic shock. Know the warning signs you should ...

Becton, Dickinson and Company announced some preliminary fiscal Q4 results recently. Read why I am reaffirming my prior buy ...

HBT Financial, Inc. (NASDAQ: HBT) (the "Company” or "HBT Financial” or "HBT”), the holding company for Heartland Bank and Trust Company, today reported net income of $19.8 million, or $0.63 diluted ...

A stylish and rugged portable SSD designed to work across smartphones, laptops and consoles, but max speeds require USB3.2 ...

Singapore’s investment market is showing renewed momentum, driven by sharper-than-expected interest rate cuts and improved ...

HONG KONG SAR - Media OutReach Newswire – 20 October 2025 - Paul Chan, Financial Secretary of the Hong Kong Special Administrative Region (HKSAR), visited the United States ...

Maxus Mining Inc. ("Maxus" or the "Company") , is pleased to announce the appointment of Mr. Robert Eckford as a Technical Advisor to the Company. Robert Eckford is a seasoned mining executive and ...